Gonik B, Cotton D, Feldman S, Cleary T G, Pickering L K
Am J Obstet Gynecol. 1984 Apr 15;148(8):1088-91. doi: 10.1016/0002-9378(84)90633-1.
Limited pharmacokinetic data exist on cefoxitin, a semisynthetic cephamycin antibiotic, in the obstetric patient. Thirteen normotensive and five subjects with severe pregnancy-induced hypertension were identified within the first two postpartum days after cesarean section. After a 2 gm intravenous infusion, serial samples of blood were obtained and analyzed for cefoxitin by high-pressure liquid chromatography. Peak cefoxitin concentrations after infusion were 53.3 +/- 18.6 and 50.8 +/- 25.2 micrograms/ml for the normotensive and pregnancy-induced hypertensive groups, respectively. The only significant difference in pharmacokinetic parameters between these groups was a higher serum trough concentration of cefoxitin in the patients with pregnancy-induced hypertension as compared to the normotensive group. Because of diminished trough levels in our study patients, attention may need to be given to the adjustment of dosages in postpartum women with serious infections.
关于半合成头孢霉素类抗生素头孢西丁在产科患者中的药代动力学数据有限。在剖宫产术后的头两天内,确定了13名血压正常的受试者和5名患有严重妊娠高血压的受试者。静脉输注2克药物后,采集系列血样,并用高压液相色谱法分析头孢西丁。血压正常组和妊娠高血压组输注后头孢西丁的峰值浓度分别为53.3±18.6和50.8±25.2微克/毫升。这两组之间药代动力学参数的唯一显著差异是,与血压正常组相比,妊娠高血压患者的头孢西丁血清谷浓度更高。由于我们研究中的患者谷浓度降低,对于患有严重感染的产后妇女,可能需要注意调整剂量。